{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:08:49Z","timestamp":1794661729038,"version":"4.9.1"},"reference-count":75,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>Follicular lymphoma (FL) is a mature B cell neoplasm classically characterized by B cells harboring the t(14;18) <jats:italic toggle=\"yes\">IGH::BCL2<\/jats:italic> leading to the overexpression of BCL2 in most cases. Conventional FL occurs in lymph nodes and typically shows a follicular B-cell proliferation expressing at least one germinal center marker. Two early lesions closely related to conventional FL are recognized as variants, namely in situ follicular neoplasia (ISFN), and duodenal-type follicular lymphoma (DTFL). FL lacking <jats:italic toggle=\"yes\">BCL2<\/jats:italic> rearrangement (<jats:italic toggle=\"yes\">BCL2<\/jats:italic>-R negative) accounts for around 10% to 15% of FLs and constitutes a heterogeneous group of FLs. Most of these alternative forms of FL are considered as distinct entities separate from conventional FL in the 2022 International Consensus Classification. This review aims to summarize the key pathologic and diagnostic features of FL conventional and its alternative forms as well as further emphasize the increasing role of molecular studies in the diagnostic work-up.<\/jats:p>","DOI":"10.1097\/pap.0000000000000481","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T10:00:06Z","timestamp":1738576806000},"page":"195-207","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Diagnosis and Classification of Follicular Lymphoma and Related Entities"],"prefix":"10.1097","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5375-7512","authenticated-orcid":false,"given":"Camille","family":"Laurent","sequence":"first","affiliation":[{"name":"Department of Pathology, Toulouse University Hospital Center, Cancer Institute University of Toulouse-Oncopole, INSERM, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Cook","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Robert J. Tomsich Institute of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"R1-20250414","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"R2-20250414","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00428-022-03432-2","article-title":"Follicular lymphoma and marginal zone lymphoma: how many diseases?","volume":"482","author":"Laurent","year":"2023","journal-title":"Virchows Arch"},{"key":"R4-20250414","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"R5-20250414","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1182\/bloodadvances.2022009456","article-title":"The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas","volume":"7","author":"Salaverria","year":"2023","journal-title":"Blood Adv"},{"key":"R6-20250414","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2006-09-045989","article-title":"CD10\u2212MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features","volume":"109","author":"Karube","year":"2007","journal-title":"Blood"},{"key":"R7-20250414","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1200\/JCO.2013.52.8190","article-title":"t(14;18) Translocation: a predictive blood biomarker for follicular lymphoma","volume":"32","author":"Roulland","year":"2014","journal-title":"J Clin Oncol"},{"key":"R8-20250414","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-20250414","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"key":"R10-20250414","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"key":"R11-20250414","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood.V99.7.2562","article-title":"Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma","volume":"99","author":"Zhu","year":"2002","journal-title":"Blood"},{"key":"R12-20250414","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1182\/blood.2023021000","article-title":"Cell cross talk within the lymphoma tumor microenvironment: follicular lymphoma as a paradigm","volume":"143","author":"Laurent","year":"2024","journal-title":"Blood"},{"key":"R13-20250414","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"key":"R14-20250414","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1182\/bloodadvances.2022008355","article-title":"Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III\/IV","volume":"6","author":"Los-de Vries","year":"2022","journal-title":"Blood Adv"},{"key":"R15-20250414","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.beha.2011.02.002","article-title":"Follicular lymphoma grade 3B","volume":"24","author":"Salaverria","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"key":"R16-20250414","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/PAS.0000000000001726","article-title":"High-grade follicular lymphomas exhibit clinicopathologic, cytogenetic, and molecular diversity extending beyond grades 3A and 3B","volume":"45","author":"Laurent","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R17-20250414","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3324\/haematol.2021.279351","article-title":"Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression\/ transformation","volume":"107","author":"Koch","year":"2022","journal-title":"Haematologica"},{"key":"R18-20250414","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3324\/haematol.12754","article-title":"Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas","volume":"93","author":"Piccaluga","year":"2008","journal-title":"Haematologica"},{"key":"R19-20250414","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3324\/haematol.2017.181024","article-title":"Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2","volume":"103","author":"Horn","year":"2018","journal-title":"Haematologica"},{"key":"R20-20250414","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjh.16159","article-title":"M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy","volume":"188","author":"Lockmer","year":"2020","journal-title":"Br J Haematol"},{"key":"R21-20250414","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood-2017-08-799080","article-title":"FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy","volume":"131","author":"Mottok","year":"2018","journal-title":"Blood"},{"key":"R22-20250414","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1470-2045(18)30102-5","article-title":"A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts","volume":"19","author":"Huet","year":"2018","journal-title":"Lancet Oncol"},{"key":"R23-20250414","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1182\/blood.2024024496","article-title":"Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significance","volume":"24","author":"Laurent","year":"2024","journal-title":"Blood"},{"key":"R24-20250414","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-based analysis of incidence and outcome of transformed non-Hodgkin\u2019s lymphoma","volume":"26","author":"Al-Tourah","year":"2008","journal-title":"J Clin Oncol"},{"key":"R25-20250414","doi-asserted-by":"crossref","first-page":"e1002197","DOI":"10.1371\/journal.pmed.1002197","article-title":"Histological transformation and progression in follicular lymphoma: a clonal evolution study","volume":"13","author":"Kridel","year":"2016","journal-title":"PLoS Med"},{"key":"R26-20250414","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/blood.2022018719","article-title":"Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns","volume":"142","author":"Dreval","year":"2023","journal-title":"Blood"},{"key":"R27-20250414","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.ajpath.2023.08.012","article-title":"Evolution of lymphoma diagnosis in the era of personalized medicine: a marriage of pathology and genomics for clinical practice","volume":"193","author":"Jaffe","year":"2023","journal-title":"Am J Pathol"},{"key":"R28-20250414","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/leu.2013.307","article-title":"Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma","volume":"28","author":"Schmidt","year":"2014","journal-title":"Leukemia"},{"key":"R29-20250414","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2018-03-837039","article-title":"CREBBP gene mutations are frequently detected in in situ follicular neoplasia","volume":"132","author":"Schmidt","year":"2018","journal-title":"Blood"},{"key":"R30-20250414","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2018-03-837252","article-title":"Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles","volume":"132","author":"Hellmuth","year":"2018","journal-title":"Blood"},{"key":"R31-20250414","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.3324\/haematol.2020.254854","article-title":"Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype","volume":"106","author":"Vogelsberg","year":"2021","journal-title":"Haematologica"},{"key":"R32-20250414","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.2016.51","article-title":"Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations","volume":"29","author":"Siddiqi","year":"2016","journal-title":"Mod Pathol"},{"key":"R33-20250414","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjh.15041","article-title":"The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion","volume":"180","author":"Zam\u00f2","year":"2018","journal-title":"Br J Haematol"},{"key":"R34-20250414","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"key":"R35-20250414","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","article-title":"Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations","volume":"128","author":"Louissaint","year":"2016","journal-title":"Blood"},{"key":"R36-20250414","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PAS.0b013e31826b9b57","article-title":"Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R37-20250414","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2012-05-429514","article-title":"Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement","volume":"120","author":"Louissaint","year":"2012","journal-title":"Blood"},{"key":"R38-20250414","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R39-20250414","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"R40-20250414","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J Clin Oncol"},{"key":"R41-20250414","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00000478-200206000-00006","article-title":"Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity","volume":"26","author":"Goodlad","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R42-20250414","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.pas.0000146015.22624.c7","article-title":"Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas","volume":"29","author":"Kim","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R43-20250414","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/PAS.0b013e31802ee4ab","article-title":"Primary follicular lymphoma of the testis and epididymis in adults","volume":"31","author":"Bacon","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R44-20250414","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1626::AID-CNCR27>3.0.CO;2-0","article-title":"Primary follicular lymphoma of the testis in childhood","volume":"85","author":"Finn","year":"1999","journal-title":"Cancer"},{"key":"R45-20250414","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00043426-200402000-00007","article-title":"Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapy","volume":"26","author":"Heller","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"R46-20250414","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MPH.0b013e31820e4636","article-title":"Primary follicular lymphoma of the testis in children and adolescents","volume":"34","author":"Lones","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"R47-20250414","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/jcp.55.9.684","article-title":"Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics","volume":"55","author":"Pileri","year":"2002","journal-title":"J Clin Pathol"},{"key":"R48-20250414","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.16578","article-title":"Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group","volume":"190","author":"Au-Yeung","year":"2020","journal-title":"Br J Haematol"},{"key":"R49-20250414","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"key":"R50-20250414","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1182\/bloodadvances.2021006034","article-title":"Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements","volume":"6","author":"Frauenfeld","year":"2022","journal-title":"Blood Advances"},{"key":"R51-20250414","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"key":"R52-20250414","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J"},{"key":"R53-20250414","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.humpath.2013.02.004","article-title":"The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-\u201cnegative\u201d grade 1\/2 follicular lymphomas","volume":"44","author":"Adam","year":"2013","journal-title":"Hum Pathol"},{"key":"R54-20250414","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.3928\/01913913-20240517-01","article-title":"Pediatric-type follicular lymphoma of the conjunctiva in two adolescents","volume":"61","author":"Shabto","year":"2024","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R55-20250414","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00428-019-02681-y","article-title":"Novel markers in pediatric-type follicular lymphoma","volume":"475","author":"Agostinelli","year":"2019","journal-title":"Virchows Arch"},{"key":"R56-20250414","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00428-015-1855-z","article-title":"Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4\/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia","volume":"468","author":"Quintanilla-Martinez","year":"2016","journal-title":"Virchows Arch"},{"key":"R57-20250414","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1182\/bloodadvances.2022007322","article-title":"A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile","volume":"6","author":"Salmeron-Villalobos","year":"2022","journal-title":"Blood Advances"},{"key":"R58-20250414","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00428-023-03493-x","article-title":"Comparison of histological and molecular features of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma","volume":"482","author":"Lee","year":"2023","journal-title":"Virchows Arch"},{"key":"R59-20250414","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/PAS.0000000000001932","article-title":"Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features","volume":"46","author":"Lim","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R60-20250414","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/modpathol.2016.102","article-title":"A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma","volume":"29","author":"Ozawa","year":"2016","journal-title":"Mod Pathol"},{"key":"R61-20250414","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","article-title":"Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene","volume":"128","author":"Schmidt","year":"2016","journal-title":"Blood"},{"key":"R62-20250414","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2017-03-776278","article-title":"Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation","volume":"130","author":"Schmidt","year":"2017","journal-title":"Blood"},{"key":"R63-20250414","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/modpathol.2008.30","article-title":"Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma","volume":"21","author":"Xie","year":"2008","journal-title":"Mod Pathol"},{"key":"R64-20250414","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humpath.2020.09.014","article-title":"The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma","volume":"106","author":"Barasch","year":"2020","journal-title":"Hum Pathol"},{"key":"R65-20250414","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1309\/AJCP4SUBR4NPSPTN","article-title":"Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions","volume":"143","author":"Pham-Ledard","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"R66-20250414","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAS.0000000000000567","article-title":"Primary cutaneous follicle center lymphomas expressing BCL2 protein frequently harbor BCL2 gene break and may present 1p36 deletion: a study of 20 cases","volume":"40","author":"Szablewski","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R67-20250414","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00000478-200604000-00015","article-title":"Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas","volume":"30","author":"Streubel","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R68-20250414","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/bloodadvances.2020002469","article-title":"Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features","volume":"5","author":"Zhou","year":"2021","journal-title":"Blood Adv"},{"key":"R69-20250414","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00428-018-2384-3","article-title":"Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein","volume":"473","author":"G\u00e1ng\u00f3","year":"2018","journal-title":"Virchows Arch"},{"key":"R70-20250414","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.3324\/haematol.2018.211631","article-title":"A high definition picture of key genes and pathways mutated in pediatric follicular lymphoma","volume":"104","author":"Lovisa","year":"2019","journal-title":"Haematologica"},{"key":"R71-20250414","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1002\/cam4.5828","article-title":"IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B-cell lymphoma","volume":"12","author":"Jiang","year":"2023","journal-title":"Cancer Med"},{"key":"R72-20250414","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00428-023-03689-1","article-title":"Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes","volume":"484","author":"Pizzi","year":"2024","journal-title":"Virchows Arch"},{"key":"R73-20250414","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00428-023-03590-x","article-title":"Emerging entities: high-grade\/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP\/SH lymphoma workshop","volume":"483","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"key":"R74-20250414","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/gcc.22014","article-title":"High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas","volume":"52","author":"Salaverria","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"R75-20250414","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humpath.2023.08.008","article-title":"Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients","volume":"141","author":"Yuan","year":"2023","journal-title":"Hum Pathol"},{"key":"R76-20250414","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2022.10.011","article-title":"Large B-cell lymphoma with IRF4 gene rearrangements: Differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients","volume":"131","author":"Berg","year":"2023","journal-title":"Hum Pathol"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T07:00:16Z","timestamp":1744614016000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0000000000000481","relation":{},"ISSN":["1072-4109","1533-4031"],"issn-type":[{"value":"1072-4109","type":"print"},{"value":"1533-4031","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}